Annotation Detail for FAM101B
Basic Information
Top
| Gene Symbol: | FAM101B ( MGC45871 ) |
|---|
| Gene Full Name: | family with sequence similarity 101, member B |
|---|
| Band: | 17p13 |
|---|
| Quick Links | Entrez ID:359845; OMIM: NA; Uniprot ID:F101B_HUMAN; ENSEMBL ID: ENSG00000183688; HGNC ID: |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C068073 |
Am 580 |
Am 580 results in increased expression of FAM101B mRNA | increases expression | 16982809
|
| C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of FAM101B mRNA | decreases expression | 17426115
|
| C089730 |
rosiglitazone |
rosiglitazone results in increased expression of FAM101B mRNA | increases expression | 16982809
|
| C025643 |
vinclozolin |
vinclozolin affects the expression of FAM101B mRNA | affects expression | 19015723
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.58 | 18653653 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.11 | 16434500 |
| MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.91 | 19621015 |
| MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.97 | 19015723 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.57 | 19483382 |
| MESH:D002386 |
Cataract |
|
Am 580 |
4.56 | 17460283 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.12 | 19176532 |
| MESH:D003092 |
Colitis |
|
Am 580 |
5.52 | 17035595 |
| MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.85 | 14966744 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.57 | 18249437 |
| MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.67 | 17446233 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
3.01 | 12642470 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
8.44 | 12083418 |
| MESH:D004487 |
Edema |
|
rosiglitazone |
8.44 | 12083418 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
9.40 | 20131406 19236843 |
| MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
9.40 | 19196556 |
| MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.57 | 16973722 |
| MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
6.02 | 16417039 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.76 | 20558911 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.55 | 16221962 18467677 19176532 19772884 |
| MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
4.24 | 12083418 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.58 | 20558911 |
| MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.29 | 16467254 |
| MESH:D007249 |
Inflammation |
|
rosiglitazone |
3.30 | 12083418 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
8.32 | 16306350 |
| MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
8.32 | 16306350 |
| MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.36 | 16417039 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.69 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
2.69 | 15980055 17347453 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.93 | 20007298 16377806 15890375 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
3.63 | 16827153 |
| MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.72 | 17261469 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.07 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.27 | 19151258 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.25 | 16411023 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.11 | 17405874 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.53 | 19015723 18220299 18042343 |
| MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.57 | 18220299 |
| MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.57 | 18629315 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.55 | 19058328 |
Related Pathway Information